4.2 Review

Biologics in Dermatology: An Integrated Review

Journal

INDIAN JOURNAL OF DERMATOLOGY
Volume 59, Issue 5, Pages 425-441

Publisher

MEDKNOW PUBLICATIONS & MEDIA PVT LTD
DOI: 10.4103/0019-5154.139859

Keywords

Biologics in dermatology; intravenous immuno-globulin; level of evidence; tumor necrosis factor - alpha

Categories

Ask authors/readers for more resources

The advent of biologics in dermatologic treatment armentarium has added refreshing dimensions, for it is a major breakthrough. Several agents are now available for use. It is therefore imperative to succinctly comprehend their pharmacokinetics for their apt use. A concerted endeavor has been made to delve on this subject. The major groups of biologics have been covered and include: Drugs acting against TNF-alpha, Alefacept, Ustekinumab, Rituximab, IVIG and Omalizumab. The relevant pharmacokinetic characteristics have been detailed. Their respective label (approved) and off-label (unapproved) indications have been defined, highlighting their dosage protocol, availability and mode of administration. The evidence level of each indication has also been discussed to apprise the clinician of their current and prospective uses. Individual anti-TNF drugs are not identical in their actions and often one is superior to the other in a particular disease. Hence, the section on anti-TNF agents mentions the literature on each drug separately, and not as a group. The limitations for their use have also been clearly brought out.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Dermatology

Cutaneous side effects of hydroxychloroquine in health care workers in a COVID referral hospital - implications for clinical practice

Kabir Sardana, Sinu Rose Mathachan, Desh Deepak, Ananta Khurana, Surabhi Sinha

Summary: This article reports cases of palmoplantar among health care workers on prophylactic doses of hydroxychloroquine and discusses their management with cetirizine and methylprednisolone.

JOURNAL OF DERMATOLOGICAL TREATMENT (2022)

Article Dermatology

Does oxidative stress correlate with disease activity and severity in alopecia areata? An analytical study

Soumya Sachdeva, Ananta Khurana, Parul Goyal, Kabir Sardana

Summary: The study compared oxidative stress parameters in patients with alopecia areata and healthy controls, finding that patients had lower levels of TAS and SOD, and higher levels of MDA. The levels of TAS and SOD decreased with disease severity, while MDA levels increased.

JOURNAL OF COSMETIC DERMATOLOGY (2022)

Article Dermatology

A real-world study of low-dose thalidomide in severe erythema nodosum leprosum highlighting its mechanistic rationale in a resource-constrained target population

Savitha Bathula, Kabir Sardana, Sinu Rose Mathachan, Ananta Khurana, Arvind Ahuja, Purnima Paliwal

Summary: Background Corticosteroids are the main therapy for erythema nodosum leprosum (ENL), but long-term usage can cause significant morbidity and mortality. Thalidomide has a dramatic effect in controlling ENL and helps reduce the dose of steroids, but cost is a hindrance to its usage.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2023)

Article Dermatology

Refractory angiolymphoid hyperplasia with eosinophilia: Complete resolution with low dose thalidomide

Ananta Khurana, B. Savitha

Summary: ALHE is a rare benign vascular proliferative condition that usually occurs in the head and neck area, particularly near the ear, presenting as painless vascular papules or nodules. We report a case of ALHE that failed multiple therapeutic interventions but achieved complete resolution when treated with thalidomide.

PEDIATRIC DERMATOLOGY (2022)

Letter Mycology

Multidrug resistant tinea corporis/cruris: Response to voriconazole

Ananta Khurana, Aastha Agarwal, Diksha Agrawal, Kabir Sardana, Ashutosh Singh, Anuradha Chowdhary

Summary: Due to increasing drug resistance and erratic clinical responses, treatment options for refractory dermatophytosis are limited. However, refractory dermatophytosis has become a significant public health issue in India in recent years. This article presents a patient who failed four systemic antifungals sequentially but was cured with a 2-week course of voriconazole, an antifungal not commonly used for dermatophytosis.

JOURNAL DE MYCOLOGIE MEDICALE (2022)

Letter Dermatology

A prospective case control study of resistance to rifampicin, dapsone and ofloxacin in Type 1 and Type 2 leprosy reactions and the therapeutic impact of modified treatment regimen on reactions

Aishwarya Muddebihal, Kabir Sardana, Ananta Khurana, Soumya Sachdeva, Itu Singh, Madhvi Ahuja, Rahul Sharma

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Article Dermatology

Effect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris A Randomized Clinical Trial

Ananta Khurana, Aastha Agarwal, Diksha Agrawal, Sanjeet Panesar, Manik Ghadlinge, Kabir Sardana, Khushboo Sethia, Shalini Malhotra, Ankit Chauhan, Nirmala Mehta

Summary: This randomized clinical trial compares the efficacy and safety of different doses of itraconazole for the treatment of tinea corporis/cruris. The study found that the 400 mg dose was superior to the 100 mg and 200 mg doses in terms of cure rates and treatment duration. However, higher doses of treatment incurred higher costs.

JAMA DERMATOLOGY (2022)

Article Dermatology

Treatment of recalcitrant cases of tinea corporis/cruris caused by T. mentagrophytes - interdigitale complex with mutations in ERG11 ERG 3, ERG4, MDR1 MFS genes & SQLE and their potential implications

Anamika Bhattacharyya, Suresh Sadhasivam, Mau Sinha, Swati Gupta, Swamini Saini, Himanshi Singh, Ananta Khurana, Soumya Sachdeva, Kabir Sardana, Shamik Ghosh

Summary: This study conducted a proteomic and genomic analysis on isolates from therapeutically recalcitrant cases of dermatophyte infections. The findings revealed gene mutations and enzymatic abnormalities that may explain the failures of antifungal treatment. Multiple gene mutations were identified in the resistant strains, including those predicting resistance to terbinafine and azole drugs, as well as efflux pumps associated with multidrug resistance.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2023)

Review Pharmacology & Pharmacy

JAK inhibitors in dermatology: the road travelled and path ahead, a narrative review

Aishwarya Muddebihal, Ananta Khurana, Kabir Sardana

Summary: JAK inhibitors have shown promising results in treating various cutaneous disorders, especially refractory conditions. However, the clinical use of JAK inhibitors in dermatology is mainly based on robust evidence for some conditions, while for others it relies on anecdotal evidence.

EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2023)

Article Public, Environmental & Occupational Health

Time to revisit the purported link of leprosy reactions with infective triggers: An unnecessary economic burden for patients

Aishwarya Muddebihal, Kabir Sardana, Ananta Khurana, Arvind Ahuja, Itu Singh

Summary: The study found that infections and pregnancy were the most common triggers for leprosy reactions, with triggers being more common in the type 2 reaction group. The study also revealed that the cost of investigations was higher in the reactional group, but extensive investigations were not justified unless there was a clear infective trigger.

TROPICAL DOCTOR (2023)

Letter Dermatology

Azathioprine induced pancytopenia with pneumonia and sepsis: A rare and potentially fatal occurence with dermatologic use

Ananta Khurana, Ritu Kumari, Karthik Lakshmanan, Piyush Jain, Sumitra Meena

INDIAN JOURNAL OF DERMATOLOGY (2023)

Letter Dermatology

Evaluation of serum levels of interleukins 6, 8, 17 and 22 in acne vulgaris: A cross-sectional study

Sweta Singh, Ananta Khurana, Anubhuti Chitkara

Summary: This study analyzed the role of interleukins (ILs) 6, 8, 17, and 22 in the pathogenesis of acne. Serum levels of IL-6, IL-8, IL-17, and IL-22 were measured and correlated with the severity of acne. The results showed that IL-8 and IL-17 play a critical role in the pathogenesis of acne, while the role of IL-6 and IL-22 is less significant.

INDIAN JOURNAL OF DERMATOLOGY (2023)

No Data Available